Clinical Trial Update: Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completion of Phase 1 and Phase 2 studies of the investigational drug NGM282 in subjects with functional constipation (and in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Constipation

Drugs mentioned

• NGM282 (Aldafermin)

Snippet

Sponsor: NGM Biopharmaceuticals, Inc | Conditions: Functional Constipation | Phase 1, Phase 2 | Status: COMPLETED